With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.34946-82-2,Copper(II) trifluoromethanesulfonate,as a common compound, the synthetic route is as follows.
To a solution of ligand L1 (50 mg, 0.2 mmol) in ethyl acetate(3 mL) was added a saturated solution of copper(II) trifluoromethanesulfonate(Cu(OTf)2) in ethyl acetate (2 mL).A blue-green precipitate appeared within 10 min, whichwas transformed into green-brown hexagonal crystalsduring slow evaporation of the solvent on standing withair contact. The crystals were collected by filtration withsuction, washed with a small volume of ethyl acetate toremove co-precipitated Cu(OTf)2. Yield: 85 mg (95%); M.p.272-274C. – IR (KBr): = 3262 m br (NH), 3147 w, 3103w, 1645 m, 1597 s, 1296 vs, 1253 vs, 1228 s, 1148 s, 1076 m,1059 m, 1029 vs, 757 w, 729 s, 629 s, 575 m, 520 m cm-1. -MS ((+)-MALDI-TOF): m/z (%) = 666.24 (100) [M-CF3SO3]+,516.26 (15) [M-2CF3SO3-H]+, 228.16 (74) [L1+H]+. – Anal. forC26H26CuF6N10O6S2 (816.21): calcd. C 38.26, H 3.21, N 17.16;found C 38.25, H 3.49, N 16.92.
34946-82-2, As the paragraph descriping shows that 34946-82-2 is playing an increasingly important role.
Reference£º
Article; Schroeder, Sven; Frey, Wolfgang; Maas, Gerhard; Zeitschrift fur Naturforschung, B: Chemical Sciences; vol. 71; 6; (2016); p. 683 – 696;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”